Cardinal Health (CAH) Q3 2024 Earnings
Cardinal Health reported Q3 2024 revenue of $54.9B, missed analyst consensus of $56.1B by $1.1B. Diluted EPS came in at $2.08, beat the $1.95 consensus by $0.13. Cardinal Health reports across 4 business segments, led by Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution (GMPD), and Nuclear and Precision Health Solutions.
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Cardinal Health's Q3 2024 earnings report.
Cardinal Health (CAH) reported Q3 2024 earnings on May 2, 2024 before market open.
Cardinal Health reported revenue of $54.9B and diluted EPS of $2.08 for Q3 2024.
Revenue missed the consensus estimate of $56.1B by $1.1B. EPS beat the consensus estimate of $1.95 by $0.13.
You can read the 10-Q periodic report (0000721371-24-000038) directly on SEC EDGAR. The filing index links above go to sec.gov.